Listed

QCR Holdings Inc: Form 10-Q for the period ended Mar 31, 2026

Filed with the SEC on May 8, 2026 and accepted by EDGAR at May 8, 2026, 14:01 ET.

Share

Management's discussion and analysis

As filed, 1,076 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On October 20, 2025, the board of directors of the Company approved a new share repurchase program under which the Company is authorized to repurchase, from time to time as the Company deems appropriate, of up to 1,700,000 shares of its common stock, or approximately 10% of the outstanding shares as of September 30, 2025. The new share repurchase program does not have an expiration date.

​ ​ ​ ​ Period ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total number of shares purchased ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average price paid per share ​ ​ ​ ​ ​ ​ ​ Total number of shares purchased as part of publicly announced plans or programs ​ ​ ​ ​ ​ ​ ​ Maximum number of shares that may still be purchased under the plans or programs ​ ​ ​ ​ ​
January 1-31, 2026 ​ 36,069 ​ ​ 86.10 ​ 185,525 ​ 1,514,475 ​
February 1-28, 2026 ​ 29,576 ​ ​ 90.28 ​ 215,101 ​ 1,484,899 ​
March 1-31, 2026 ​ 181,644 ​ ​ 83.68 ​ 396,745 ​ 1,303,255 ​

Risk factors

As filed, 2,979 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Other than as set forth below, there have been no material changes in the risk factors applicable to the Company from those disclosed in Part I, Item 1A., “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Please refer to that section of the Company’s Form 10-K for disclosures regarding the other risks and uncertainties related to the Company’s business.

Litigation and regulatory actions could subject the Company to significant fines, penalties, judgments or other requirements resulting in increased expenses or restrictions on the Company’s business activities.

The Company’s business is subject to increased litigation and regulatory risks because of a number of factors, including the highly regulated nature of the financial services industry and the focus of state and federal prosecutors on banks and the financial services industry generally. This focus has only intensified in recent years, with regulators and prosecutors focusing on a variety of financial institution practices and requirements, including foreclosure practices, compliance with applicable consumer protection laws, classification of “held for sale” assets and compliance with anti-money laundering statutes, the Bank Secrecy Act and sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury.

In the normal course of business, from time to time, the Company and its subsidiaries have in the past and may in the future be named as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with their current or prior business activities. Legal actions could include claims for substantial compensatory or punitive damages or claims for indeterminate amounts of damages. The outcomes of legal actions such as these are unpredictable and subject to significant uncertainties, and it is inherently difficult to determine whether any loss is probable or even possible. It is also inherently difficult to estimate the amount of any loss and there may be matters for which a loss is probable or reasonably possible but not currently estimable. Accordingly, actual losses may be in excess of any estimates, established accruals or the range of reasonably possible losses. It is possible that the ultimate resolution of any such matter, if unfavorable, may be material to the Company’s results of operations for any particular period. Any exposure of the Company to significant financial liability or reputational harm may adversely impact demand for the Company’s products and services or otherwise have a material adverse effect on its reputation, business, financial condition, results of operations and growth prospects. For example, CSB was named as a defendant in a proposed class action lawsuit with respect to overdraft fees. Additional information regarding this litigation is included in Note 12 to the Consolidated Financial Statements.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Income tax3 months2026-01-01 to 2026-03-31$2.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-01-01 to 2026-03-31$33.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2026-01-01 to 2026-03-31$1.99us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-01-01 to 2026-03-31$2.00us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-01-01 to 2026-03-3116,741,541 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2026-01-01 to 2026-03-31$4.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2026-01-01 to 2026-03-31$12.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Total assetsAt period end2026-03-31$9.61bnus-gaap:Assets
Total liabilitiesAt period end2026-03-31$8.49bnus-gaap:Liabilities
Short-term borrowingsAt period end2026-03-31$1.9mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2026-03-31$1.12bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-26-057779. Last ingested by Listed: Nov 5, 2026, 14:00 ET. Listed shows no prices and gives no investment advice.